Show simple item record

dc.contributor.authorMody, Nimesh
dc.contributor.authorMcIlroy, George David
dc.date.accessioned2015-09-30T23:00:56Z
dc.date.available2015-09-30T23:00:56Z
dc.date.issued2014-10-01
dc.identifier.citationMody , N & McIlroy , G D 2014 , ' The mechanisms of Fenretinide-mediated anti-cancer activity and prevention of obesity and type-2 diabetes ' , Biochemical Pharmacology , vol. 91 , no. 3 , pp. 277-286 . https://doi.org/10.1016/j.bcp.2014.07.012en
dc.identifier.issn0006-2952
dc.identifier.otherPURE: 40009152
dc.identifier.otherPURE UUID: 72ecabd4-eccb-47f0-9a22-feaa2976d874
dc.identifier.otherPubMed: 25069047
dc.identifier.otherScopus: 84925736785
dc.identifier.otherORCID: /0000-0002-2215-7952/work/36967397
dc.identifier.urihttp://hdl.handle.net/2164/4958
dc.identifier.urihttp://www.sciencedirect.com/science/article/pii/S0006295214004183en
dc.descriptionCopyright © 2014. Published by Elsevier Inc. Acknowledgments This work was supported by the British Heart Foundation Intermediate Basic Research Fellowship FS/09/026/27398 to N.M. and Biotechnology and Biological Sciences Research Council doctoral training grant awarded to G.D.M.en
dc.format.extent10
dc.language.isoeng
dc.relation.ispartofBiochemical Pharmacologyen
dc.rightsNOTICE: this is the author’s version of a work that was accepted for publication in Biochemical Pharmacology. Changes resulting from the publishing process, such as peer review, editing, corrections, structural formatting, and other quality control mechanisms may not be reflected in this document. Changes may have been made to this work since it was submitted for publication. A definitive version was subsequently published in BIOCHEMICAL PHARMACOLOGY, [VOL 91, ISSUE 3, (2014)] DOI: 10.1016/j.bcp.2014.07.012en
dc.subjectapoptosisen
dc.subjectautophagyen
dc.subjectreactive oxygen speciesen
dc.subjectretinoic aciden
dc.subjectadipogenesisen
dc.subjectobesityen
dc.subjecttype-2 diabetesen
dc.subjectRM Therapeutics. Pharmacologyen
dc.subjectBiotechnology and Biological Sciences Research Council (BBSRC)en
dc.subjectBritish Heart Foundationen
dc.subjectSDG 3 - Good Health and Well-beingen
dc.subject.lccRMen
dc.titleThe mechanisms of Fenretinide-mediated anti-cancer activity and prevention of obesity and type-2 diabetesen
dc.typeJournal articleen
dc.contributor.institutionUniversity of Aberdeen.Medical Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Medical Sciences - Cardiovascular Groupen
dc.contributor.institutionUniversity of Aberdeen.Medicine, Medical Sciences & Nutrition, Vascular Healthen
dc.contributor.institutionUniversity of Aberdeen.Rowett Instituteen
dc.contributor.institutionUniversity of Aberdeen.Institute of Medical Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Clinical Medicineen
dc.description.statusPeer revieweden
dc.description.versionPostprinten
dc.identifier.doihttps://doi.org/10.1016/j.bcp.2014.07.012
dc.date.embargoedUntil2015-10-01
dc.identifier.urlhttp://www.sciencedirect.com/science/article/pii/S0006295214004183en


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record